Advertisement, Author at Pharmaceutical Business review - Page 60 of 69
Pharmaceutical Business review is using cookies

ContinueLearn More

All articles by  

FDA panel recommends approval of Rituxan biosimilar

The regulator’s Oncologic Drugs Advisory Committee voted unanimously recommending approval of CT-P10, a proposed monoclonal antibody (mAb) biosimilar to Rituxan, to treat adult patients in three proposed indications.